Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | C150 - EEG: Normal EEG, Normal Variants, and How to Avoid the Common Pitfall of Overreading

Thursday 04/07/22
07:00 AM - 09:00 AM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Aatif M. Husain, MD
Epilepsy/Clinical Neurophysiology (EEG)
Participants should appreciate the basic normal EEG patterns; recognize common normal variants; and understand how to minimize the chance of misinterpretation of normal EEG. This program complements EEG: Focal, Diffuse, and Epileptiform Abnormalities in Adults & EEG: Neonatal and Pediatric but covers independent topics.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:05 AM PDT Speaker Introduction
Aatif M. Husain, MD
07:00 AM - 07:00 AM PDT Speaker Walk-in Slides
Aatif M. Husain, MD
07:05 AM - 07:40 AM PDT Speaker Normal EEG Patterns
Meriem K. Bensalem Owen, MD
07:40 AM - 08:15 AM PDT Speaker Normal EEG Variants
Aatif M. Husain, MD
08:15 AM - 08:50 AM PDT Speaker Avoiding EEG Reading Pitfalls
Michael *use 154496 Westover
08:50 AM - 09:00 AM PDT Q&A Questions and Answers
Aatif M. Husain, MD, Meriem K. Bensalem Owen, MD, Michael *use 154496 Westover
Faculty Disclosures
Aatif M. Husain, MD Dr. Husain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Husain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlackThorn Pharmaceuticals. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuiticals. Dr. Husain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Marinus Pharmaceuticals. Dr. Husain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis Pharmaceuitcals. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Pharmaceuticals. Dr. Husain has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Husain has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Husain has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for International Federation of Clinical Neurophysiology. Dr. Husain has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Clinical Neurophysiology Society. Dr. Husain has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. The institution of Dr. Husain has received research support from Marinus Pharmaecuticals. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has a non-compensated relationship as a Vice Chair of CNP MOC committee with American Board of Psychiatry and Neurology that is relevant to AAN interests or activities.
Meriem K. Bensalem Owen, MD The institution of Dr. Bensalem Owen has received research support from NIH. The institution of Dr. Bensalem Owen has received research support from Xenon. The institution of Dr. Bensalem Owen has received research support from UCB. The institution of Dr. Bensalem Owen has received research support from NeuroPace.
Michael *use 154496 Westover Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care.